These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Studies on the adrenergic receptor specificity of inhibitors of phenylethanolamine N-methyltransferase. Pendleton RG; Hieble JP Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):399-408. PubMed ID: 6119751 [TBL] [Abstract][Full Text] [Related]
68. Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase. Fuller RW; Hemrick-Luecke SK; Perry KW Biochem Pharmacol; 1983 Jan; 32(2):215-20. PubMed ID: 6870951 [No Abstract] [Full Text] [Related]
69. Inhibition of norepinephrine N-methyltransferase by 1-aminoindans, conformationally rigid analogs of benzylamines. Fuller RW; Roush BW; Hemrick SK; Snoddy HD; Molloy BB Life Sci; 1978 Apr; 22(16):1421-7. PubMed ID: 672406 [No Abstract] [Full Text] [Related]
70. The effect of some phenylethanolamine N-methyltransferase inhibitors on the adrenaline content in the domestic fowl diencephalon. Juorio AV; Durden DA Can J Biochem; 1977 Jul; 55(7):761-5. PubMed ID: 890570 [TBL] [Abstract][Full Text] [Related]
71. Kinetic and pH studies on human phenylethanolamine N-methyltransferase. Wu Q; McLeish MJ Arch Biochem Biophys; 2013 Nov; 539(1):1-8. PubMed ID: 24018397 [TBL] [Abstract][Full Text] [Related]
72. Antihypertensive effects of CGS 19281A, an inhibitor of phenylethanolamine-N-methyltransferase. Chatelain RE; Manniello MJ; Dardik BN; Rizzo M; Brosnihan KB J Pharmacol Exp Ther; 1990 Jan; 252(1):117-25. PubMed ID: 2153796 [TBL] [Abstract][Full Text] [Related]
73. Effects of various inhibitors of phenylethanolamine N-methyltransferase on pulsatile release of LH in ovariectomized rats. Coen CW; Gallo RV J Endocrinol; 1986 Oct; 111(1):51-9. PubMed ID: 3783085 [TBL] [Abstract][Full Text] [Related]
74. Evidence for interaction between central beta-2 adrenoceptors and epinephrine pathways in the opioid-induced prolactin rise in the rat. De Castro-e-Silva E; Antunes-Rodrigues J Braz J Med Biol Res; 1988; 21(5):1057-63. PubMed ID: 3248234 [TBL] [Abstract][Full Text] [Related]
75. Metabolism of 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline, a phenylethanolamine N-methyltransferase inhibitor. I. Disposition following administration to the rat and dog. Intoccia AP; Levandoski P; Joseph G; Wittendorf R; Girman C; Walkenstein SS; Hwang BY Xenobiotica; 1981 May; 11(5):301-9. PubMed ID: 7293220 [No Abstract] [Full Text] [Related]
77. The effect of epinephrine on phenylethanolamine N-methyltransferase in cultured explants of adrenal medulla. Burke WJ; Davis JW; Joh TH; Reis DJ; Horenstein S; Bhagat BD Endocrinology; 1978 Aug; 103(2):358-67. PubMed ID: 744091 [TBL] [Abstract][Full Text] [Related]
78. Epinephrine and recovery from punishment. Holz WC; Pendleton RG; Fry WT; Gill CA J Pharmacol Exp Ther; 1977 Aug; 202(2):379-87. PubMed ID: 886470 [TBL] [Abstract][Full Text] [Related]
79. Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT. Grunewald GL; Caldwell TM; Dahanukar VH; Jalluri RK; Criscione KR Bioorg Med Chem Lett; 1999 Feb; 9(3):481-6. PubMed ID: 10091706 [TBL] [Abstract][Full Text] [Related]
80. Importance of the aromatic ring in adrenergic amines. 5. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of hydrophobic and steric interactions. Vincek WC; Aldrich CS; Borchardt RT; Grunewald GL J Med Chem; 1981 Jan; 24(1):7-12. PubMed ID: 7205880 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]